Xeris Biopharma Holdings Inc (XERS)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current XERS market cap is 680.42M. The company's latest EPS is USD -0.3562 and P/E is -12.41.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 44.39M | 40.64M | 48.07M | 54.27M | 60.1M |
| Operating Income | -9.84M | -14.25M | -8.19M | -12.89M | 1.68M |
| Net Income | -13.39M | -18.98M | -15.01M | -15.74M | -5.11M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 49.59M | 110.25M | 163.91M | 203.07M |
| Operating Income | -115.16M | -81.94M | -44.01M | -33.65M |
| Net Income | -122.73M | -94.66M | -62.26M | -54.84M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 322.6M | 336.62M | 331.73M | 321.1M | 323.06M |
| Total Liabilities | 329.38M | 345.79M | 351.02M | 349.43M | 352.68M |
| Total Equity | -6.78M | -9.18M | -19.29M | -28.32M | -29.62M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 304.36M | 344.52M | 322.6M | 323.06M |
| Total Liabilities | 209.13M | 299.34M | 329.38M | 352.68M |
| Total Equity | 95.23M | 45.19M | -6.78M | -29.62M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -47.02M | -20.3M | -30.65M | -38.96M | -36.98M |
| Investing | -6M | -19.65M | -15.05M | -5.13M | 4.88M |
| Financing | -1.61M | 35.19M | 35.85M | 35.77M | 36.17M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -95.54M | -102.89M | -47.02M | -36.98M |
| Investing | 97.96M | 34.46M | -6M | 4.88M |
| Financing | 27.25M | 127.47M | -1.61M | 36.17M |
| Market Cap | 680.42M |
| Price to Earnings Ratio | -12.41 |
| Price to Sales Ratio | 3.35 |
| Price to Cash Ratio | 9.5 |
| Price to Book Ratio | -22.98 |
| Dividend Yield | - |
| Shares Outstanding | 153.94M |
| Average Volume (1 week) | 4.32M |
| Average Volume (1 Month) | 4.36M |
| 52 Week Change | 115.61% |
| 52 Week High | 6.07 |
| 52 Week Low | 1.69 |
| Spread (Intraday) | 0.01 (0.23%) |
| Company Name | Xeris Biopharma Holdings Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.xerispharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
